InvestorLens

PFE — PFIZER INC

Health Care · Drug Manufacturers

Sign in to save6 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying PFE?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Net accumulation · 1 buying vs 0 selling last quarter
70
Macro Tailwind
Macro conditions are mixed for this sector
53
Congressional Activity
0 congressional purchases, 2 sales disclosed in the last 6 months
Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their PFE position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime). 0 congressional purchases, 2 sales disclosed in the last 6 months.

Supporting evidence
  • +1 tracked investor added or increased positions last quarter (Ray Dalio)
  • +6 tracked investors reported holding PFE at their latest filing
Contradicting evidence — always shown
  • −Congressional disclosures lean toward selling (2 sales vs 0 purchases, 6 months)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About PFIZER INC (PFE)

PFIZER INC (PFE) appears in the most recent 13F filings of 6 tracked institutional investors. PFIZER INC is classified in the Health Care sector (Drug Manufacturers industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $1.7B. Across recent filings, tracked investors recorded 6 new positions, 4 increased, 5 reduced, and 4 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in PFE

53
/100
Mixed Activity
Added / Increased10
Reduced5
Exited4
BearishBullish
Crowded Trade Score™

How many top investors track PFE

40
/100
Moderate Interest
6investors

Several tracked investors have exposure.

UndiscoveredCrowded
151015+

PFE Ownership Composition

How PFIZER INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
85% of tracked value
Institutions
6
tracked investors
Total Reported
$1.3B
combined 13F value
Types3
  • Multi-Strategy / Quant85.2%
  • Value & Distressed12.2%
  • Macro2.6%
Multi-Strategy / Quant(3)
85.2%
Value & Distressed(1)
12.2%
Macro(2)
2.6%

Tracked investors currently reporting PFE

1 tracked investor has since exited this position — listed separately below.

  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    32.7M
    Value
    $787.6M
    % Portfolio
    0.09%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    6.8M
    Value
    $162.7M
    % Portfolio
    0.06%
  • Steve CohenJun 30, 2026
    Point72 Asset Management
    Shares
    4.8M
    Value
    $116.6M
    % Portfolio
    0.13%
  • Michael BurrySep 30, 2025
    Scion Asset Management
    Shares
    6M
    Value
    $152.9M
    % Portfolio
    11.07%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    1.2M
    Value
    $27.7M
    % Portfolio
    0.04%
  • Ray DalioJun 30, 2026
    Bridgewater Associates
    Shares
    180.1K
    Value
    $4.3M
    % Portfolio
    0.02%

Previously held PFE

These investors reported PFE in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Cathie WoodARK Investment Management499.8K$14.4MDec 31, 2023

Recent activity

Frequently asked questions

How many institutional investors hold PFE?
6 tracked institutional investors disclosed a position in PFE (PFIZER INC) in their most recent 13F filing.
Who is the largest institutional holder of PFE?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in PFE, valued at $1.7B.
Did institutional ownership of PFE increase or decrease?
Across recent 13F filings, tracked investors recorded 6 new positions, 4 increased, 5 reduced, and 4 fully exited PFE.
What sector is PFE in?
PFIZER INC is classified in the Health Care GICS sector, Drug Manufacturers industry.
Where does this PFE ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
PFE (PFIZER INC) — Institutional Holders & 13F History — InvestorLens